TY - JOUR AU - Liu, Xinyan AU - Fu, Jinming AU - Bi, Haoran AU - Ge, Anqi AU - Xia, Tingting AU - Liu, Yupeng AU - Sun, Hongru AU - Li, Dapeng AU - Zhao, Yashuang PY - 2019 DA - 2019/12/12 TI - DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients JO - BMC Cancer SP - 1212 VL - 19 IS - 1 AB - As biomarkers, DNA methylation is used to detect colorectal cancer (CRC) and make assessment of CRC prognosis. The published findings showed the association between the methylation of SFRP1, SFRP2, and WIF1, located in the Wnt signaling pathway, and the prognosis of CRC were not consistent. Our study aimed to explore the potential possibility of SFRP1, SFRP2, and WIF1 concomitant promoter methylation as prognostic biomarkers of postoperative CRC patients. SN - 1471-2407 UR - https://doi.org/10.1186/s12885-019-6436-0 DO - 10.1186/s12885-019-6436-0 ID - Liu2019 ER -